Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2019-05-02 AGM Information
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
Procès-Verbal AGM UCB 2019.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "PROCES-VERBAL" (Minutes) of the "ASSEMBLEE GENERALE ORDINAIRE DES ACTIONNAIRES TENUE A BLUEPOINT BRUXELLES, AVENUE A.REYERS 80 - 1030 BRUXELLES LE JEUDI 25 AVRIL 2019 A 11 HEURES" (Ordinary General Meeting of Shareholders held on Thursday, April 25, 2019). The content details the constitution of the meeting, verification of proxies, the agenda (including approval of 2018 annual accounts, remuneration report, discharge to directors, and board member renewals/appointments), and the resulting decisions. This perfectly matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting.
2019-05-02 French
Notulen Algemene Vergadering UCB 2019.pdf
AGM Information Classification · 99% confidence The document is explicitly titled 'UCB NV - GEWONE ALGEMENE VERGADERING VAN AANDEELHOUDERS GEHOUDEN TE BLUEPOINT BRUSSELS... OP DONDERDAG 25 APRIL 2019 OM 11 UUR' and contains 'NOTULEN' (Minutes). The agenda items cover the approval of the annual accounts, remuneration report, discharge of directors, and renewal/appointment of board members, which are standard procedures for an Annual General Meeting (AGM). Although it discusses annual results (related to 10-K/ER), the context is the formal meeting where these are presented and voted upon. Therefore, the most appropriate classification is AGM Information.
2019-05-02 Dutch
190425 UCB AGM 2019 ANG final.pdf
AGM Information Classification · 99% confidence The document explicitly states it is about 'UCB's General Meeting of Shareholders' and details the outcomes of the Annual General Meeting (AGM), including dividend approval (€ 1.21 per share), reappointment/appointment of directors, and confirmation that 'All other agenda items put to vote at the AGM were approved'. This content directly relates to the proceedings and results of the AGM. Although it mentions the Integrated Annual Report 2018, the primary focus and structure of this release are to report the meeting's events and voting outcomes. Therefore, the most appropriate classification is AGM Information (AGM-R).
2019-04-25 English
190425 UCB AGM 2019 FR final.pdf
AGM Information Classification · 98% confidence The document text is a press release titled 'Assemblée générale des actionnaires d'UCB' (UCB Shareholders' General Meeting). It explicitly discusses the outcomes of the Annual General Meeting (AGO), including the approval of the 2018 dividend (€ 1.21 per share) and the re-election/election of board members. This content directly relates to the proceedings and materials shared during the Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). The document is a summary/release about the meeting, not the formal minutes or voting results (DVA), nor the full annual report (10-K).
2019-04-25 French
180425 UCB AGM 2019 NL final .pdf
Notice of Dividend Amount Classification · 99% confidence The document text is titled 'Algemene vergadering van aandeelhouders UCB' (General Meeting of Shareholders UCB) and discusses the approval of the gross dividend for fiscal year 2018, the re-appointment of directors, and confirms that all agenda items were approved. This content directly relates to the proceedings and outcomes of an Annual General Meeting (AGM). Although it mentions the Integrated Annual Report 2018 is available, the primary focus and nature of this specific document is the announcement of the AGM results and key decisions made therein. Therefore, the most appropriate classification is AGM Information (AGM-R).
2019-04-25 Dutch
190410 - Transparency notification press release Blackrock .pdf
Major Shareholding Notification Classification · 99% confidence The document is titled 'Transparency notification BlackRock, Inc.' and explicitly states that it is a notification received by UCB SA/NV pursuant to Article 14 of the law on the disclosure of large shareholdings. It details the crossing of a 5% ownership threshold by BlackRock, Inc. and provides specific figures for voting rights and equivalent financial instruments before and after the transaction. This content directly corresponds to reporting requirements for changes in significant share ownership, which maps to the 'Major Shareholding Notification' category (MRQ). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific insider/major shareholder transaction disclosure.
2019-04-10 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.